Cliff Kalb is President and owner of C. Kalb & Associates, a pharmaceutical industry consultancy that specializes in intelligence, analysis, and strategy. He has four decades of experience in the pharmaceutical industry, both as a consumer and producer of intelligence. Cliff was formerly Senior Vice President with Wood Mackenzie’s Life Sciences Consultancy, and served as the Head of Strategic Business Analysis at Merck & Co, Inc., their global intelligence function. He previously held positions of increasing responsibility in sales, market research, health economics, public policy, marketing, licensing and business development at Pfizer and Roche. He has been actively engaged in both studies and execution of business arrangements including licensing, joint marketing, joint ventures, mergers and acquisitions in the industry for the past 25 years.
Mr. Kalb is Past President of both SCIP (Strategic and Competitive Intelligence Professionals) and PBIRG (Pharmaceutical Business Intelligence and Research Group) and earned their Lifetime Achievement Award. He has also served Chairman of the Conference Board Council on Competitive Analysis. He is the current Chair of the SCIP Fellows Council, and the 2013 SCIP Meritorious Award winner. He has been named as one of the top 100 most inspiring people in the pharmaceutical industry by Pharmavoice, and serves on the Advisory Board of Pharmaceutical Executive Magazine. His body of work in intelligence and analysis is widely published and respected. Cliff holds a Bachelor’s in Biology and Psychology from Rutgers University, and an MBA in Pharmaceutical Marketing and Economics from Fairleigh Dickinson University.